Hemab Therapeutics Holdings, Inc. (COAG)
Nasdaq: COAG · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2026
The company now
Hemab Therapeutics Holdings, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836). Its latest filed balance sheet shows total assets of $175 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.